Tuesday Talks — Embracing Neurodivergent Children To Thrive in a New World of Learning

Tuesday, February 6, 2024

Presented by Seema Kumar, CEO, Cure

Seventy million people in the United States have dyslexia, ADHD, and other conditions that make them act and think different. Join us to learn how the nonprofit is supporting and helping these people to navigate everything from school to jobs, and to prosper through training and advice for patients, families, teachers, and others—while raising awareness with caregivers and the public.

Tuesday Talks — Embracing Neurodivergent Children To Thrive in a New World of Learning

When: Tuesday, February 6 2024, 5:30 PM – 7:30 PM ET
Where: Cure, 345 Park Avenue South, New York, NY 10010

Topic: A fireside chat to talk about the seventy million people in the US with dyslexia, ADHD, and other conditions, and more.

Speakers: Nathan Friedman, Co-President & Chief Marketing Officer at Moderated by Seema Kumar, CEO of Cure.

Featured Speakers

Nathan Friedman

About Nathan Friedman

Nathan began his career at Ogilvy, where he drove strategic marketing and communications efforts, and held numerous roles, including managing director of its Chicago office and global account leader. He eventually led the firm’s four-office West Coast operation where he directed the rollout of the Affordable Care Act in California. Previous roles include General Manager of a mid-sized agency and President of a consultancy focused on branding and marketing strategy for startups in the impact space. He serves on the board of directors of the Point Foundation – the nation’s largest LGBTQ+ scholarship fund.

Seema Kumar

About Seema Kumar

Seema joined Cure Experience in 2022 as the Chief Executive Officer. Prior to Cure, Ms. Kumar spent nearly 20 years at Johnson & Johnson in senior leadership roles, including most recently as the Global Head, Office of Innovation, Global Health and Scientific Engagement, and served on J&J’s Innovation Strategy, Public health leadership and the COVID-19 vaccine steering committee, where she led the company’s external affairs efforts and public education program on COVID and vaccine literacy. Before her tenure at J&J, Ms. Kumar was the Chief of Staff to Dr. Eric Lander and the Chief Communications Officer at the Whitehead Institute/Massachusetts Institute of Technology Center for Genome Research where she played a leadership role in the Human Genome Project. She also has held leadership positions at the U.S. National Institutes of Allergy and Infectious Diseases (NIAID), the National Institutes of Health, and Johns Hopkins School of Medicine. Ms. Kumar holds an M.S. in Science Journalism and Communications from the University of Maryland.